Highmark Expands Coverage for AppliedVR's Innovative Therapy
Highmark Expands Coverage for Virtual Reality Therapy
FDA-authorized RelieVRx is now a covered treatment for Highmark's commercial members experiencing chronic low back pain (CLBP)
AppliedVR, a pioneer in immersive therapeutics, has exciting news to share. Highmark, a leading health insurance plan, has officially decided to cover the innovative treatment known as RelieVRx. This device is designed to help individuals suffering from chronic low back pain, making it an essential resource for health management. This decision opens doors for over four million Highmark members to access a therapeutic approach that employs the power of virtual reality (VR) to assist in pain management.
What is RelieVRx?
RelieVRx delivers a unique and fully immersive virtual reality experience aimed at empowering individuals to develop skills for managing their pain effectively. As a non-pharmacologic treatment option, this device provides a cost-effective alternative to conventional therapies. Clinical studies have shown that it significantly reduces pain intensity and interference, catering to a diverse range of users across various demographics.
Program Details and Usability
The RelieVRx program consists of a structured 56-session regimen. Patients engage in daily VR sessions that tackle the different aspects - biological, psychological, and social - of their pain experience. Designed for self-administration, patients can conveniently use the device right in their homes. Clinical trials have consistently shown high usability ratings for RelieVRx, confirming its effectiveness and user-friendly interface.
Clinical Evidence and Accessibility
Highmark’s decision to add RelieVRx to its coverage was guided by a thorough analysis of applied clinical studies from AppliedVR. One notable study, which involved more than 1,000 participants, demonstrated that the device significantly impacts pain reduction. Patients diagnosed with moderate to severe chronic low back pain can now easily obtain prescriptions for this treatment from their healthcare providers without any need for prior authorization.
Statements from Leadership
In a recent statement, Matt Fickie, Senior Medical Director for Highmark, emphasized the importance of technology in improving health outcomes while controlling costs. He stated, "RelieVRx from AppliedVR provides our members suffering from chronic low back pain a scientifically backed, in-home immersive non-opioid treatment option." Such insight underlines the collaboration between health insurance and innovative therapeutic solutions.
The Economic and Social Impact of Chronic Pain
Chronic pain is a pressing issue within the United States, with significant financial implications. It is estimated to cost the economy about $635 billion annually, contributing to the escalating opioid crisis. Additionally, approximately 72 million Americans are reported to suffer from chronic low back pain, recognizing it as a leading cause of disability. Addressing this issue is critical to improving public health and economic stability.
Vision for Future Treatment Options
Matthew Stoudt, Co-founder and CEO of AppliedVR, expressed gratitude towards Highmark for their forward-thinking approach. He spotlighted the importance of noninvasive, drug-free options that provide individuals with the ability to manage their pain. Through the combination of clinical evidence and immersive therapy, AppliedVR aims to reshape how pain is experienced and treated.
Expansion and Momentum for AppliedVR
While Highmark stands out as the first commercial health insurance provider to cover RelieVRx, AppliedVR has recently gained significant traction with other health plans as well. Noteworthy developments include the receipt of a unique code and pricing determination from the Centers for Medicare and Medicaid Services, marking AppliedVR as a leader in its category. Furthermore, the implementation of RelieVRx in several Veterans Affairs sites indicates increasing acceptance and recognition of the therapy in various healthcare systems.
Conclusion
As healthcare continues to evolve, integrating innovative solutions like RelieVRx sets a new standard for pain management. The collaboration between Highmark and AppliedVR not only enhances patient care but also promotes a greater understanding of alternative treatments in managing chronic conditions. Through this partnership, the future looks hopeful for many suffering from chronic low back pain.
Frequently Asked Questions
What is RelieVRx?
RelieVRx is a virtual reality device designed to provide immersive therapy for individuals suffering from chronic low back pain.
Who can access RelieVRx through Highmark?
Eligible commercial members aged 18 and older diagnosed with moderate to severe chronic low back pain can access the device with a prescription.
How does the RelieVRx program work?
The program consists of a 56-session regimen that patients complete mostly in their homes, using daily VR sessions to manage pain.
Is there any cost associated with accessing RelieVRx through Highmark?
Highmark's coverage allows eligible patients to obtain the device without prior authorization, making it more accessible.
How has the response been to RelieVRx?
Clinical studies show high usability ratings for RelieVRx, demonstrating positive feedback from participants on its effectiveness in pain management.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- ROKFORM Unveils Durable Cases for Apple's iPhone 16 Release
- How Roundtable's $RTB Token is Transforming Journalism
- Exciting Growth Ahead for Industrial Smart Sensors Market
- Westen Reichtum Launches Dynamic Strategies for Crypto Investors
- Innovative Partnership Sets Stage for EV Charging Expansion
- Transforming a Tiny Home into a Lucrative Passive Income Source
- Philer AI Gains Approval from Ontario's Legal Society for Innovation
- Transform Your Investment: Discover GoDaddy's Growth Journey
- Important Update for WEBTOON Entertainment Inc. Investors
- OcuDyne Celebrates Key Milestone in Clinical Trial for AMD
Recent Articles
- Introducing Kabir Goyal: New Portfolio Manager at Boston Trust Walden
- Unleashing the 2025 Durango SRT Hellcat Hammerhead Edition
- Microfluidic Chips Market Growth Driven by Innovation and Demand
- NIL Platform Nilly Partners With Harlan Capital to Help Athletes
- Alpha Partners Successfully Completes $153 Million Fund III
- Elevating Digital Lending: Planet Home Lending's Strategic Move
- Transform Your Life with the Inspiring Coffee Table Book
- Veritran Expands Presence with New North American Office
- MNA Nurses Stand United at Marlborough Hospital for Change
- Cuprina Holdings Pursues Initial Public Offering with 3.75M Shares
- Carmakers Adjust EV Strategies Amid Softening Demand Trends
- Exploring Upcoming Stock Splits: Key Company Insights
- Legal Action for Investors of CVS Health Corporation Securities
- Empowering Future Leaders: CHLI's Fall 2024 Global Class
- SafeTea Introduces Innovative App to Enhance Dating Safety
- Lawsuit Filed Against Workforce West Virginia for Harassment
- New Audit Quality Standards Set to Transform Financial Reporting
- JPMorgan Expands Mid-Cap Investment Banking Team with New Hires
- PIN AI Secures $10M in Funding for Revolutionary AI Platform
- Cork Protocol Joins Forces to Revolutionize DeFi Risk Management
- Introducing ZKcandy Voyage Public Testnet for Gamers Worldwide
- Palantir Stock Surges: A Look at Its Future Potential
- Shazia Miller Returns to Elevate Education at American Institutes
- Fuel Storage Tank Market Growth Driven by Renewable Demand
- Global mRNA Vaccine Market Poised for Major Growth by 2034
- Discover National Fuel's Commitment to Sustainability in 2023
- Shell plc Announces Major Share Buyback Activity
- Insight into GTT's Share Capital and Voting Rights Update
- Concerns Emerge Over Nvidia's Concentrated Client Base
- Understanding Big Bets on Riot Platforms and Market Trends
- Special Opportunities Fund Announces Upcoming Dividend Payment
- Exploring Current Trends in MongoDB's Options Trading
- Schwab Trading Activity Index Displays Resilience Amid Changes
- Understanding Unity Software's Recent Options Activities
- Bluespring Wealth Partners Celebrates Industry Award Success
- Paul Eitelman Discusses the Appeal of Small-Cap Investments
- Transforming $100 into a Fortune: The DexCom Success Story
- Transforming $1000 into a Wealthy Investment with ONTO
- T-Mobile's Stock Journey: Fluctuations and Future Growth Potential
- Pembina Pipeline Corporation Expands Infrastructure Footprint
- Venteur Partners with UBA to Revolutionize Employee Benefits
- Investigating Potential Shareholder Violations in Three Companies
- Wipfli's Report Highlights Outsourcing as a Strategic Tool
- Revolutionary Sliding Door Series from Alpen Enhances Homes
- Owl Therapeutics Reaches New Heights in TBI Treatment Development
- FanDuel Casino Celebrates $1 Million Summer Sweepstakes Win
- Family Care Center Enhances Mental Health Services through New Scale
- Institutional Investors Boost Equity Hedge Fund Allocations
- Celsius Holdings Experiences Notable Options Trading Trends
- Fisher House Foundation Awards Educational Scholarships